Patents by Inventor Si Eun PARK

Si Eun PARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11547649
    Abstract: The present invention pertains to: a botulinum toxin, epithelial cell growth factor, or hexapeptide fusion protein bound to skin tissues and cell-permeable peptides, or an epithelial cell growth factor mixed with skin tissues and cell-permeable peptides; and a composition comprising same. The fusion protein or the epithelial cell growth factor mixed with cell-permeable peptides has increased cell permeability compared to protein by itself, and is thus useful for improving the condition of skin, treating wrinkles, relieving muscle tension, and treating wounds.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: January 10, 2023
    Assignee: AVIXGEN INC.
    Inventors: Yi Yong Baek, Woo Ri Shin, Si Eun Park, Jun Sub Choi, Hye Cheong Koo
  • Publication number: 20210251872
    Abstract: The present invention pertains to: a botulinum toxin, epithelial cell growth factor, or hexapeptide fusion protein bound to skin tissues and cell-permeable peptides, or an epithelial cell growth factor mixed with skin tissues and cell-permeable peptides; and a composition comprising same. The fusion protein or the epithelial cell growth factor mixed with cell-permeable peptides has increased cell permeability compared to protein by itself, and is thus useful for improving the condition of skin, treating wrinkles, relieving muscle tension, and treating wounds.
    Type: Application
    Filed: June 7, 2019
    Publication date: August 19, 2021
    Applicant: Avixgen Inc.
    Inventors: Yi Yong BAEK, Woo Ri SHIN, Si Eun PARK, Jun Sub CHOI, Hye Cheong KOO